ATM gene variants in patients with idiopathic perifoveal telangiectasia

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 9, 2008, Pages 3806-3811

  Barbazetto, Irene A ^a,b   Room, Miia ^a   Yannuzzi, Nicholas A ^a   Barile, Gaetano R ^a   Merriam, Joanna E ^a   Bardal, Anne M C ^b   Bailey Freund, K ^a,b   Yannuzzi, Lawrence A ^a,b   Allikmets, Rando ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA SCREENING; EUROPEAN AMERICAN; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE SEQUENCE; GENETIC VARIABILITY; HISPANIC; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; IDIOPATHIC PERIFOVEAL TELANGIECTASIA; INDIAN; MALE; OPHTHALMOLOGY; OPHTHALMOSCOPY; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; STANDARD; TELANGIECTASIA; VISUAL ACUITY; ATAXIA TELANGIECTASIA; GENETICS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RETINA FOVEA; RETINA MACULA LUTEA;

ATM PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; FOVEA CENTRALIS; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS); VISUAL ACUITY;

EID: 53149095822     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1357     Document Type: Article

References (34)

1. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993;100(10):1536-1546. (Pubitemid 23292864)
2. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124(4):450-460.
3. Leys A, Gilbert HD, Van De Sompel W, et al. Familial spastic paraplegia and maculopathy with juxtafoveolar retinal telangiectasis and subretinal neovascularization. Retina. 2000;20(2):184-189. (Pubitemid 30395714)
4. Spaide RF, Borodoker N, Shah V. Atypical choroidal neovascularization in radiation retinopathy. Am J Ophthalmol. 2002;133(5):709-711. (Pubitemid 34462026)
5. Chew EY, Murphy RP, Newsome DA, Fine SL. Parafoveal telangiectasis and diabetic retinopathy. Arch Ophthalmol. 1986;104(1):71-75.
6. Maberley DA, Yannuzzi LA, Gitter K, et al. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. Ophthalmology. 1999;106(12):2248-2252, discussion 2252-2253. (Pubitemid 30191434)
7. Mauget-Faysse M, Vuillaume M, Quaranta M, et al. Idiopathic and radiation-induced ocular telangiectasia: the involvement of the ATM gene. Invest Ophthalmol Vis Sci. 2003;44(8):3257-3262. (Pubitemid 36909756)
8. Gatti RA, Berkel I, Boder E, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988;336(6199):577- 580. (Pubitemid 19007315)
9. Platzer M, Rotman G, Bauer D, et al. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res. 1997;7(6):592-605. (Pubitemid 27313608)
10. Shiloh Y. ATM: ready, set, go. Cell Cycle. 2003;2(2):116-117.
11. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3(3):155-168. (Pubitemid 37328868)
12. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432(7015):316-323.
13. Lavin MF, Birrell G, Chen P, et al. ATM signaling and genomic stability in response to DNA damage. Mutat Res. 2005;569(1-2):123-132. (Pubitemid 39643262)
14. Miles PD, Treuner K, Latronica M, et al. Impaired insulin secretion in a mouse model of ataxia telangiectasia. Am J Physiol Endocrinol Metab. 2007;293(1):E70-E74.
15. Kuljis RO, Chen G, Lee EY, et al. ATM immunolocalization in mouse neuronal endosomes: implications for ataxia-telangiectasia. Brain Res. 1999;842(2):351-358. (Pubitemid 29475169)
16. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102(20):7227- 7232.
17. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38(4):458-462.
18. Dork T, Bendix R, Bremer M, et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 2001;61(20):7608-7615. (Pubitemid 32995055)
19. Larson GP, Zhang G, Ding S, et al. An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet Test 1997. 1998;1:165-170. (Pubitemid 128537139)
20. Maillet P, Bonnefoi H, Vaudan-Vutskits G, et al. Constitutional alterations of the ATM gene in early onset sporadic breast cancer. J Med Genet. 2002;39:751-753. (Pubitemid 35178726)
21. Maillet P, Chappuis PO, Vaudan G, et al. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer. 2000;88:928-931.
22. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308(5720):421- 424.
23. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308(5720):419-421. (Pubitemid 40530081)
24. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389. (Pubitemid 40530070)
25. Chenevix-Trench G, Spurdle AB, Gatei M, et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002;94(3):205-215. (Pubitemid 34162754)
26. Takao N, Li Y, Yamamoto K. Protective roles for ATM in cellular response to oxidative stress. FEBS Lett. 2000;472(1):133-136. (Pubitemid 30224601)
27. Dodson GE, Tibbetts RS. DNA replication stress-induced phosphorylation of cyclic AMP response element-binding protein mediated by ATM. J Biol Chem. 2006;281(3):1692-1697.
28. Shi Y, Venkataraman SL, Dodson GE, et al. Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004;101(16):5898-5903. (Pubitemid 38520500)
29. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821-861.
30. Wahlin KJ, Campochiaro PA, Zack DJ, Adler R. Neurotrophic factors cause activation of intracellular signaling pathways in Muller cells and other cells of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci. 2000;41(3):927-936. (Pubitemid 30158910)
31. Gatti RA, Tward A, Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab. 1999;68(4):419-423. (Pubitemid 30043548)
32. Bonnen PE, Story MD, Ashorn CL, et al. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am J Hum Genet. 2000;67(6):1437-1451.
33. Broeks A, Urbanus JH, Floore AN, et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet. 2000;66(2):494-500. (Pubitemid 30468827)
34. Broeks A, Braaf LM, Huseinovic A, et al. The spectrum of ATM missense variants and their contribution to contralateral breast cancer. Breast Cancer Res Treat. 2008;107:243-248. (Pubitemid 350265692)